Home/Pipeline/Next-Generation Branched Endograft System

Next-Generation Branched Endograft System

Complex aortic aneurysms involving major arterial branches (e.g., visceral, renal)

Pre-clinicalActive

Key Facts

Indication
Complex aortic aneurysms involving major arterial branches (e.g., visceral, renal)
Phase
Pre-clinical
Status
Active
Company

About Red Vascular Technologies

Red Vascular Technologies is a private, pre-revenue medical device innovator targeting the challenging market of complex aortic aneurysms. Its core technology is a non-modular, branched endoprosthesis delivered via a single access site, aiming to replace the current standard of complex modular and fenestrated grafts. Founded by seasoned medical device inventors with a track record of commercial success, the company is in the development stage, seeking to translate its simplified design into clinical use with the potential for safer, more efficient procedures.

View full company profile

Therapeutic Areas